MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 535754 | Name: BM 11

Description:

WARNING: This product is for research use only, not for human or veterinary use.

BM 11 is a bioactive chemical.

Chemical Structure

BM 11
BM 11
CAS#137783-15-4

Theoretical Analysis

MedKoo Cat#: 535754

Name: BM 11

CAS#: 137783-15-4

Chemical Formula: C19H30N4O2S2

Exact Mass: 410.1810

Molecular Weight: 410.60

Elemental Analysis: C, 55.58; H, 7.36; N, 13.65; O, 7.79; S, 15.62

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
BM 11; BM-11; BM11
IUPAC/Chemical Name
3-Pyridinesulfonamide, 4-(cycloheptylamino)-N-((cyclohexylamino)thioxomethyl)-
InChi Key
FIIQKQAZIRPFIC-UHFFFAOYSA-N
InChi Code
InChI=1S/C19H30N4O2S2/c24-27(25,23-19(26)22-16-10-6-3-7-11-16)18-14-20-13-12-17(18)21-15-8-4-1-2-5-9-15/h12-16H,1-11H2,(H,20,21)(H2,22,23,26)
SMILES Code
O=S(C1=C(NC2CCCCCC2)C=CN=C1)(NC(NC3CCCCC3)=S)=O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 410.60 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Jang S, Park S, Jang BH, Park YL, Lee JA, Cho CS, Go HY, Shin YC, Ko SG. Study protocol of a pragmatic, randomised controlled pilot trial: clinical effectiveness on smoking cessation of traditional and complementary medicine interventions, including acupuncture and aromatherapy, in combination with nicotine replacement therapy. BMJ Open. 2017 Jun 2;7(5):e014574. doi: 10.1136/bmjopen-2016-014574. PMID: 28576892; PMCID: PMC5623405. 2: Theunissen PMJ, Sedek L, De Haas V, Szczepanski T, Van Der Sluijs A, Mejstrikova E, Nováková M, Kalina T, Lecrevisse Q, Orfao A, Lankester AC, van Dongen JJM, Van Der Velden VHJ; EuroFlow Consortium. Detailed immunophenotyping of B-cell precursors in regenerating bone marrow of acute lymphoblastic leukaemia patients: implications for minimal residual disease detection. Br J Haematol. 2017 Jul;178(2):257-266. doi: 10.1111/bjh.14682. Epub 2017 Apr 17. PMID: 28419441. 3: Namba H, Kawasaki M, Izumi M, Ushida T, Takemasa R, Ikeuchi M. Effects of MRgFUS Treatment on Musculoskeletal Pain: Comparison between Bone Metastasis and Chronic Knee/Lumbar Osteoarthritis. Pain Res Manag. 2019 Sep 2;2019:4867904. doi: 10.1155/2019/4867904. PMID: 31565109; PMCID: PMC6745150. 4: Bowman IA, Bent A, Le T, Christie A, Wardak Z, Arriaga Y, Courtney K, Hammers H, Barnett S, Mickey B, Patel T, Whitworth T, Stojadinovic S, Hannan R, Nedzi L, Timmerman R, Brugarolas J. Improved Survival Outcomes for Kidney Cancer Patients With Brain Metastases. Clin Genitourin Cancer. 2019 Apr;17(2):e263-e272. doi: 10.1016/j.clgc.2018.11.007. Epub 2018 Dec 5. PMID: 30538068; PMCID: PMC6534272. 5: Yomo S, Oguchi K. Prospective study of 11C-methionine PET for distinguishing between recurrent brain metastases and radiation necrosis: limitations of diagnostic accuracy and long-term results of salvage treatment. BMC Cancer. 2017 Nov 6;17(1):713. doi: 10.1186/s12885-017-3702-x. PMID: 29110648; PMCID: PMC5674753. 6: Dankerl A, Liebisch P, Glatting G, Friesen C, Blumstein NM, Kocot D, Wendl C, Bunjes D, Reske SN. Multiple Myeloma: Molecular Imaging with 11C-Methionine PET/CT--Initial Experience. Radiology. 2007 Feb;242(2):498-508. doi: 10.1148/radiol.2422051980. Epub 2006 Dec 19. PMID: 17179397. 7: Wong NA, Warren BF, Piris J, Maynard N, Marshall R, Bodmer WF. EpCAM and gpA33 are markers of Barrett's metaplasia. J Clin Pathol. 2006 Mar;59(3):260-3. doi: 10.1136/jcp.2005.027474. Epub 2006 Feb 10. PMID: 16473928; PMCID: PMC1860330. 8: Fusch G, Mitra S, Topp H, Agarwal A, Yiu SH, Bruhs J, Rochow N, Lange A, Heckmann M, Fusch C. Source and Quality of Enteral Nutrition Influences Oxidative Stress in Preterm Infants: A Prospective Cohort Study. JPEN J Parenter Enteral Nutr. 2018 Nov;42(8):1288-1294. doi: 10.1002/jpen.1156. Epub 2018 Mar 30. PMID: 29603266. 9: Vetlova E, Golbin DA, Golanov AV, Potapov AA, Banov SM, Antipina N, Kostjuchenko VV, Usachev DY, Belyaev AY, Goryaynov S. Preoperative Stereotactic Radiosurgery of Brain Metastases: Preliminary Results. Cureus. 2017 Dec 26;9(12):e1987. doi: 10.7759/cureus.1987. PMID: 29503781; PMCID: PMC5826747. 10: Blakley BW, Alsaleh S, Dewji Z, Qureshy K, Berard S, Xie L. Steroids in aminoglycoside-containing ear drops: do they reduce cochlear toxicity? Laryngoscope. 2014 May;124(5):1209-13. doi: 10.1002/lary.24475. Epub 2013 Dec 13. PMID: 24142776.

View History

Dienone B

Dienone B